StonvexLoading…
StonvexStonvexStonvexCore line items from ANDG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $240.75M | $838.69M | $208.07M | $731.59M |
Operating Income | $24.08M | $-135.29M | $52.65M | $129.54M |
Net Income | $494.00K | $-2.32M | $50.58M | $134.80M |
EPS (Diluted) | $0.03 | $-0.22 | Not available | Not available |
Total Assets | $608.57M | $565.14M | Not available | $398.69M |
Total Liabilities | $579.88M | $593.52M | Not available | $202.44M |
Cash & Equivalents | $206.81M | $250.28M | $95.22M | $87.99M |
Free Cash Flow OCF − CapEx | $-7.57M | $174.27M | $9.96M | $143.72M |
Shares Outstanding | 14.81M | 110.94M | Not available | Not available |